Zkusit zdarma
Profound Medical Corp.

Profound Medical Corp.

PROF
Cena:
$ 6.83
-0.14 (-2.01%)
Valuace
100
Růst
85
Zdraví
75

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí

close

JOHNS HOPKINS MEDICINE TREATS FIRST COMMERCIAL TULSA-PRO® CASE

06-01-2026
PROFOUND MEDICAL MARKS MAJOR MILESTONE AS THE HOSPITAL LAUNCHES ITS STATE-OF-THE-ART IMRI SUITE TO E...

PROFOUND MEDICAL CORP. ANNOUNCES CLOSING OF PRIVATE PLACEMENT

30-12-2025
TORONTO, DEC. 30, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL CORP. ANNOUNCES UPSIZE OF PRIVATE PLACEMENT

24-12-2025
TORONTO, DEC. 24, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL CORP. CLOSES $36 MILLION REGISTERED DIRECT OFFERING; EXPECTS TO COMPLETE SUBSEQUENT PRIVATE PLACEMENT ON OR BEFORE DECEMBER 30TH

23-12-2025
FINANCING INCLUDED PARTICIPATION BY HEALTHCARE-DEDICATED INVESTORS ALONGSIDE EXISTING SHAREHOLDERS F...

PROFOUND MEDICAL CORP. ANNOUNCES PRICING OF UP TO $40 MILLION FINANCING COMPRISED OF A $36 MILLION REGISTERED DIRECT OFFERING AND A SUBSEQUENT $4 MILLION PRIVATE PLACEMENT

19-12-2025
TORONTO, DEC. 19, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

STANFORD MEDICINE'S DR. PEJMAN GHANOUNI RECEIVES RSNA'S CUM LAUDE AWARD FOR CAPTAIN PERIOPERATIVE DATA PRESENTATION

04-12-2025
– CAPTAIN IS THE FIRST RANDOMIZED CONTROLLED TRIAL EVER COMPARING A NEW TECHNOLOGY TO THE STANDARD...

PROFOUND MEDICAL TO LAUNCH AI-POWERED BPH MODULE, PRESENT NEW TULSA-PRO® CLINICAL DATA, AT RSNA AND SUO MEETINGS

28-11-2025
NEW BPH MODULE AND CLINICAL DATA REINFORCE THE TULSA PROCEDURE™'S VERSATILITY IN PROSTATE DISEASE,...

PROFOUND MEDICAL CELEBRATES THE HONG CENTER'S 200TH INDEPENDENT TULSA PROCEDURE FOR PROSTATE DISEASE

18-11-2025
RENOWNED UROLOGIST DR. MARK HONG SETS NEW GLOBAL BENCHMARK FOR UROLOGIST-LED, MRI-GUIDED PROSTATE TR...

PROFOUND MEDICAL REPORTS STRONG THIRD QUARTER 2025 FINANCIAL RESULTS

13-11-2025
TORONTO, NOV. 13, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL ANNOUNCES STRATEGIC DISTRIBUTION AGREEMENT WITH GETZ HEALTHCARE TO BRING TULSA-PRO® TO AUSTRALIA AND NEW ZEALAND

12-11-2025
TORONTO, NOV. 12, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL INKS EXCLUSIVE DISTRIBUTION AGREEMENT FOR TULSA-PRO® AND SONALLEVE® WITH AL FAISALIAH MEDICAL SYSTEMS IN SAUDI ARABIA

11-11-2025
AGREEMENT CREATES RUNWAY FOR PROFOUND'S INCISION-FREE AND RADIATION-FREE THERAPIES FOR THE ABLATION ...

PROFOUND MEDICAL TO PARTICIPATE IN THE STIFEL 2025 HEALTHCARE CONFERENCE

14-10-2025
TORONTO, OCT. 14, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL ACHIEVES RECORD PRELIMINARY UNAUDITED REVENUE FOR THE 2025 THIRD QUARTER

07-10-2025
TO RELEASE FULL THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13TH; CONFERENCE CALL TO FOLLOW TO ...

TEXAS PROSTATE AND DALLAS MEDICAL CENTER LAUNCH FIRST-OF-ITS-KIND TULSA PROGRAM, EXPANDING ACCESS TO ADVANCED PROSTATE TREATMENT

23-09-2025
NEW PROGRAM DELIVERS TULSA PROCEDURE'S PRECISION TREATMENT - MINIMAL SIDE EFFECTS, NO OVERNIGHT HOSP...

PROFOUND MEDICAL TO PARTICIPATE IN LAKE STREET'S 9TH ANNUAL BEST IDEAS GROWTH CONFERENCE

28-08-2025
TORONTO, AUG. 28, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS

14-08-2025
TORONTO, AUG. 14, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL TO RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 14 – CONFERENCE CALL TO FOLLOW

24-07-2025
TORONTO, JULY 24, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOUN...

PROFOUND MEDICAL ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS VOTING RESULTS

14-05-2025
TORONTO, MAY 14, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (TSX: PRN; NASDAQ: PROF) (“PROFOU...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

03-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 3, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF ...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

01-05-2025
POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. ("PROFOUND" O...

PROFOUND MEDICAL TO PARTICIPATE IN THE 2025 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

30-04-2025
TORONTO, APRIL 30, 2025 (GLOBE NEWSWIRE) -- PROFOUND MEDICAL CORP. (NASDAQ:PROF; TSX:PRN) (“PROFOU...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

30-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 30, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

29-04-2025
NEW YORK, APRIL 29, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...

INITIAL PERIOPERATIVE DATA FROM CAPTAIN RANDOMIZED TRIAL DEMONSTRATE MRI-GUIDED TULSA PROVIDES STATISTICALLY SIGNIFICANT IMPROVEMENT OF POST-OPERATIVE EXPERIENCE VS. ROBOTIC RADICAL PROSTATECTOMY

29-04-2025
– FIRST LEVEL 1 STUDY COMPARING AN EMERGING TECHNOLOGY HEAD-TO-HEAD WITH RP IN MEN WITH PROSTATE C...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

28-04-2025
NEW YORK , APRIL 28, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

25-04-2025
NEW YORK, APRIL 25, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

24-04-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / APRIL 24, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHA...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

23-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 23, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

21-04-2025
NEW YORK, APRIL 21, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PROFOUND MEDICAL CORP. - PROF

20-04-2025
NEW YORK, NY / ACCESS NEWSWIRE / APRIL 20, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF...

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-12 00:00:008-KStáhnout
2026-02-05 00:00:008-KStáhnout
2026-01-28 00:00:008-KStáhnout
2026-01-15 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2026-01-06 00:00:008-KStáhnout
2025-12-31 00:00:008-KStáhnout
2025-12-19 00:00:008-KStáhnout
2025-11-28 00:00:008-KStáhnout
2025-11-13 00:00:0010-QStáhnout
2025-11-12 00:00:008-KStáhnout
2025-10-07 01:00:008-KStáhnout
2025-10-07 00:00:008-KStáhnout
2025-08-14 01:00:008-KStáhnout
2025-08-14 01:00:0010-QStáhnout
2025-08-14 00:00:008-KStáhnout
2025-08-14 00:00:0010-QStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-04-29 01:00:008-KStáhnout
2025-04-29 00:00:008-KStáhnout
2025-04-22 01:00:008-KStáhnout
2025-04-22 00:00:008-KStáhnout
2025-03-07 00:00:008-KStáhnout
2025-03-07 00:00:0010-KStáhnout
2025-03-06 23:00:008-KStáhnout
2025-03-06 23:00:0010-KStáhnout
2025-01-08 00:00:008-KStáhnout
2025-01-07 23:00:008-KStáhnout
preloader